BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16786721)

  • 1. Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall.
    Zhou M; Magi-Galluzzi C; Epstein JI
    Anal Quant Cytol Histol; 2006 Jun; 28(3):125-9. PubMed ID: 16786721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
    Zhou M; Shah R; Shen R; Rubin MA
    Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma].
    Kong X; Deng F; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):199-201. PubMed ID: 9275650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
    Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
    Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical pitfalls in prostate pathology.
    Brimo F; Epstein JI
    Hum Pathol; 2012 Mar; 43(3):313-24. PubMed ID: 22325142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
    Wu A; Kunju LP
    Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p63 in differentiating morphologically ambiguous lesions of prostate.
    Baig MK; Hassan U; Mansoor S
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):773-7. PubMed ID: 23217483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
    Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
    Saad RS; Liu YL; Silverman JF
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review.
    Enciu M; Aşchie M; Boşoteanu M; Chisoi A
    Rom J Morphol Embryol; 2012; 53(4):1093-6. PubMed ID: 23303039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
    Helpap B; Köllermann J; Oehler U
    J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach.
    Helpap B
    Virchows Arch; 1998 Nov; 433(5):397-405. PubMed ID: 9849853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical basal cell hyperplasia of the prostate.
    Epstein JI; Armas OA
    Am J Surg Pathol; 1992 Dec; 16(12):1205-14. PubMed ID: 1281386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall.
    Tian W; Dorn D; Wei S; Sanders RD; Matoso A; Shah RB; Gordetsky J
    Histopathology; 2017 Jul; 71(1):150-155. PubMed ID: 28316088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.